AnalystsAndrea TanAndrea Tan's Stock Forecasts
AnalystsAndrea Tan
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#3771 out of 4337 analysts
Average Return
-11.88%
Win Rate
29%4 out of 14
Risk vs Reward
Poor
Good
Andrea Tan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fate Therapeutics IncFATE | +85.36% | $14.21 | $2.08 | 2022-12-14 - 2023-09-25 | Strong Sell |
Fate Therapeutics IncFATE | +60.53% | $5.27 | $2.08 | 2023-01-08 - 2023-09-25 | Strong Sell |
Insmed IncINSM | +44.91% | $17.79 | $25.78 | 2023-01-08 - 2023-09-25 | Strong Buy |
Verve Therapeutics IncVERV | +41.50% | $19.52 | $11.42 | 2022-12-14 - 2023-09-25 | Strong Sell |
Andrea Tan Analyst Color
Get additional color on Andrea Tan's coverage of popular stocks
Andrea Tan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Day One Biopharmaceuticals IncDAWN | 3 | Strong Buy | $54.00 | +320.89% | Maintains | 2 months ago |
Sagimet Biosciences IncSGMT | 1 | Strong Buy | $33.00 | +245.19% | Initiates Coverage On | 2 months ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $24.00 | +403.14% | Maintains | 2 months ago |
Insmed IncINSM | 2 | Strong Buy | $39.00 | +51.28% | Maintains | 9 months ago |
Fate Therapeutics IncFATE | 2 | Strong Sell | $4.00 | +92.31% | Maintains | 9 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Strong Buy | $375.00 | +148.44% | Maintains | 9 months ago |
Verve Therapeutics IncVERV | 1 | Strong Sell | $13.00 | +13.84% | Initiates Coverage On | 9 months ago |
Codiak Biosciences IncCDAKQ | 3 | Hold | $1.40 | +2,356.14% | Maintains | a year ago |
Relmada Therapeutics IncRLMD | 2 | Hold | $8.00 | +158.06% | Downgrades | a year ago |
Vor Biopharma IncVOR | 1 | Hold | $6.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.